Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
RIPK3 mediates pathogenesis of experimental ventilator-induced lung injury
Ilias I. Siempos, … , Kiichi Nakahira, Augustine M.K. Choi
Ilias I. Siempos, … , Kiichi Nakahira, Augustine M.K. Choi
Published May 3, 2018
Citation Information: JCI Insight. 2018;3(9):e97102. https://doi.org/10.1172/jci.insight.97102.
View: Text | PDF
Research Article Pulmonology

RIPK3 mediates pathogenesis of experimental ventilator-induced lung injury

  • Text
  • PDF
Abstract

In patients requiring ventilator support, mechanical ventilation (MV) may induce acute lung injury (ventilator-induced lung injury [VILI]). VILI is associated with substantial morbidity and mortality in mechanically ventilated patients with and without acute respiratory distress syndrome. At the cellular level, VILI induces necrotic cell death. However, the contribution of necroptosis, a programmed form of necrotic cell death regulated by receptor-interacting protein-3 kinase (RIPK3) and mixed-lineage kinase domain-like pseudokinase (MLKL), to the development of VILI remains unexplored. Here, we show that plasma levels of RIPK3, but not MLKL, were higher in patients with MV (i.e., those prone to VILI) than in patients without MV (i.e., those less likely to have VILI) in two large intensive care unit cohorts. In mice, RIPK3 deficiency, but not MLKL deficiency, ameliorated VILI. In both humans and mice, VILI was associated with impaired fatty acid oxidation (FAO), but in mice this association was not observed under conditions of RIPK3 deficiency. These findings suggest that FAO-dependent RIPK3 mediates pathogenesis of acute lung injury.

Authors

Ilias I. Siempos, Kevin C. Ma, Mitsuru Imamura, Rebecca M. Baron, Laura E. Fredenburgh, Jin-Won Huh, Jong-Seok Moon, Eli J. Finkelsztein, Daniel S. Jones, Michael Torres Lizardi, Edward J. Schenck, Stefan W. Ryter, Kiichi Nakahira, Augustine M.K. Choi

×

Figure 7

Administration of carnitine palmitoyl transferase inhibitor in mice and exposure to mechanical ventilation.

Options: View larger image (or click on image) Download as PowerPoint
Administration of carnitine palmitoyl transferase inhibitor in mice and ...
(A–C) Changes in (A) lung elastance were recorded, and bronchoalveolar lavage fluid (BALF) was measured for (B) total protein concentration and (C) lactate dehydrogenase (LDH) in WT mice after treatment or not with a carnitine palmitoyl transferase (CPT1) inhibitor, perhexiline, and exposure to mechanical ventilation (MV) at low or high tidal volume (low VT or high VT). (D–F) Changes in (D) lung elastance were recorded, and BALF was measured for (E) total protein concentration and (F) LDH in Ripk3–/– and WT mice after treatment with perhexiline and exposure to MV at low or high tidal volume. Data are presented as mean ± SEM (*P < 0.05; **P < 0.01; ***P < 0.001). ANOVA with Tukey post hoc correction was used for all comparisons.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts